An interventional study of Baduanjin exercise and General Health Education in Sedentary Lifestyle and Behavioral Intervention, sponsored by China-Japan Friendship Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 59 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by China-Japan Friendship Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Sedentary Behavior with a site in China — 10 open to participants now, 11 under way, none of them phase 3. Sedentary Behavior · China.
Among the 23 studies in Sedentary Behavior with a site in China, this one is the 3rd largest by planned enrollment, is one of 9 that started in 2026, is one of 23 with no phase, reaches primary completion later than 8 of the 10 other live ones, and was the 13th registered.
1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.
Browse Sedentary Behavior studies →10 of the 23 studies in Sedentary Behavior with a site in China are open now. Recruiting first, the newest first:
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences · Sites in China
Ages 18–40 · Healthy volunteers
Affiliated Hospital of Nantong University · Sites in China
Ages 30+
Universiti Sains Malaysia · Sites in China
Ages 18–25 · Healthy volunteers
Universiti Putra Malaysia · Sites in China
Ages 18–22 · Healthy volunteers
Shenzhen University · Sites in China
Ages 18–30 · Healthy volunteers
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.
This study: 18 Years to 59 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
First in 2022; this study’s year is marked. 9 started in 2026.
This study's planned enrollment of 208 is above the median of 60 across 1,077 interventional studies indexed under Sedentary Behavior.
Median enrollment 75 across the 23 interventional studies. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 23 has an industry lead sponsor. The 10 most frequent:
China-Japan Friendship Hospital is the lead sponsor of 179 studies on the registry; 112 are open to participants now.
China-Japan Friendship Hospital has 1 study filed under Sedentary Behavior — fewer than ten, so there is no comparison to draw.
6 of the studies in Sedentary Behavior with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06923163Shenzhen Institutes of Advanced Technology ,Chinese Academy of SciencesThe Effect of Exercise on Metabolic Alteration | 2026-12 |
| NCT07762898Gansu University of Chinese MedicineSedentary Behavior Intervention for Older Adults With Coronary Heart Disease and Frailty | 2027-01 |
| NCT07934030Shenzhen UniversityBreaks in Sedentary Behaviour and Executive Function | 2027-02-23 |
| NCT07593118The Children's Hospital of Zhejiang University School of MedicineExergame-Based Physical Activity Promotion for Children and Adolescents With Congenital Heart Disease | 2027-07-31 |
| NCT07482995China-Japan Friendship HospitalEffects of Baduanjin Exercise on Improving Health in Sedentary Young and Middle-Aged Adults | 2027-09-30 |
Add all 6 to your calendar (.ics) → With an account.
Among the 23 studies in Sedentary Behavior with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if a 12-week Baduanjin exercise program can improve health in sedentary young and middle-aged adults. The main questions it aims to answer are:
Researchers will compare the Baduanjin training group to a health education control group to see if Baduanjin is more effective in improving these health outcomes.
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group will receive a 12-week Baduanjin exercise program. The program consists of supervised group sessions combined with home-based practice, with a frequency of 5 sessions per week. Each session lasts 60 minutes, including warm-up, standardized Baduanjin practice, and cool-down. The Baduanjin exercises follow a standardized protocol.
Behavioral: Baduanjin exercise
Participants in this group will receive general health education, which includes recommendations on physical activity types and duration (e.g., following the WHO guidelines). However, they will not be enrolled in any structured, supervised exercise program. They will be instructed to maintain their usual lifestyle throughout the study period.
Other: General Health Education
A 12-week, standardized Baduanjin exercise program. Participants will complete 5 sessions per week, each lasting 60 minutes (including warm-up, Baduanjin practice, and cool-down). The program includes both supervised group sessions and guided home practice.
Participants will receive general health education (including recommendations on physical activity types and duration), but will not be enrolled in any structured or supervised exercise program. They will be instructed to maintain their usual lifestyle.
Change in Peak Oxygen Uptake (VO₂peak) assessed by Cardiopulmonary Exercise Testing
Measured by Cardiopulmonary Exercise Testing (CPET).
Time frame: at baseline and Week 13.
Change in Sit-and-Reach Distance
Assessed by the standard sit-and-reach test.
Time frame: at baseline, Week 8, and Week 13.
Change in Active Range of Motion of the Shoulder, Hip, Knee, and Ankle joints assessed by Goniometry
Measured using a goniometer
Time frame: at baseline, Week 8, and Week 13.
Change in Time Spent in Sedentary Behavior assessed by the International Physical Activity Questionnaire (IPAQ)
Time frame: at baseline and Week 13.
Scores on the Exercise Benefits/Barriers Scale (EBBS)
The scale consists of two subscales: the Exercise Benefits Subscale (29 items) and the Exercise Barriers Subscale (14 items). The total score ranges from 43 to 172, with a higher score indicating a more positive perception towards exercise.
Time frame: at baseline and Week 13
Change in Knee Extension Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during knee extension
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Extension Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal knee extension contractions.
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Extension Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Extension Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Flexion Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Knee Flexion measured at a preset angular velocity
Time frame: at baseline, Week 8, and Week 13
Change in Knee Flexion Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Knee Flexion contractions
Time frame: at baseline, Week 8, and Week 13
Change in Knee Flexion Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Knee Flexion Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Shoulder Flexion, measured at a preset angular velocity.
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Shoulder Flexion contractions
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Shoulder Abduction , measured at a preset angular velocity
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Shoulder Abduction contractions
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Elbow Extension, measured at a preset angular velocity
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Elbow Extension contractions
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Elbow Flexion, measured at a preset angular velocity
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Elbow Flexion contractions
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Rhythmic Weight Shift (RWS) Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Time frame: at baseline, Week 8, and Week 13.
Change in Modified Clinical Test of Sensory Interaction on Balance (mCTSIB) Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Time frame: at baseline, Week 8, and Week 13.
Change in Sensory Organization Test (SOT) Composite Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Time frame: at baseline, Week 8, and Week 13.
Change in Motor Control Test (MCT) Latency assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Time frame: at baseline, Week 8, and Week 13.
Change in Limits of Stability (LOS) Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Time frame: at baseline, Week 8, and Week 13.
Change in Muscle Mass assessed by Bioelectrical Impedance Analysis
Time frame: at baseline and Week 13.
Change in Body Fat Percentage assessed by Bioelectrical Impedance Analysis
Time frame: at baseline and Week 13.
Change in Fat-Free Mass assessed by Bioelectrical Impedance Analysis
Time frame: at baseline and Week 13.
Change in Waist-to-Hip Ratio
Ratio of waist circumference to hip circumference
Time frame: at baseline and Week 13.
Change in Center of Mass Sway Amplitude during Baduanjin Exercise assessed by 3D Motion Capture
Magnitude of anteroposterior and mediolateral displacement of the body's center of mass during static postures of Baduanjin, analyzed using a markerless 3D motion capture system
Time frame: at baseline and Week 13
Change in Joint Range of Motion during Baduanjin Exercise assessed by 3D Motion Capture
Angular displacement of primary joints during the performance of Baduanjin movements, analyzed using a markerless 3D motion capture system.
Time frame: at baseline and Week 13
Change in Center of Mass Height during Baduanjin Exercise assessed by 3D Motion Capture
Time frame: at baseline and Week 13
Change in Integrated Electromyography (iEMG) during Baduanjin Exercise assessed by Surface Electromyography
Time frame: at baseline and Week 13
Change in Root Mean Square (RMS) Amplitude during Baduanjin Exercise assessed by Surface Electromyography
Time frame: at baseline and Week 13
Change in Glycemic Control Biomarkers
Fasting venous blood samples will be analyzed for indicators of glucose metabolism, such as glycated hemoglobin (HbA1c) and fasting insulin.
Time frame: at baseline and Week 13.
Change in Lipid Profile
Fasting venous blood samples will be analyzed for indicators of lipid metabolism, including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C).
Time frame: at baseline and Week 13.
Change in Inflammatory and Neurotrophic Biomarkers
Fasting venous blood samples will be analyzed for inflammatory markers (e.g., high-sensitivity C-reactive protein \[hs-CRP\], interleukin-6 \[IL-6\], tumor necrosis factor-alpha \[TNF-α\]) and brain-derived neurotrophic factor (BDNF).
Time frame: at baseline and Week 13.
Percentage of Prescribed Baduanjin Sessions Completed
Time frame: Through study completion, up to Week 13.
Baduanjin Movement Quality Score assessed by Blinded Expert Review (100-point scale)
Score assessed by blinded experts using a standardized 100-point scoring rubric. Scores range from 0 to 100, with a higher score indicating better movement quality.
Time frame: at Week 13
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Sep 2027, 12 months after the start.
Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 12 months is below that.
Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: start Apr 2026 → Sep 2026, primary completion Jul 2027 → Sep 2027 and completion Aug 2027 → Oct 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
China-Japan Friendship Hospital →